September 2015 Newsletter

September 17, 2015:

US Ophthalmic Procedures Grow 3.0 Percent in Q2-2015

Refractive surgery continues to experience tepid demand despite an improving economy; cataract surgery volume was higher than expected.

September 17, 2015:

2015 ESCRS Meeting Draws Record Crowd with High-Interest Topics, Products

Conference has raised its profile with packed agenda, popular locations.

September 17, 2015:

2015 ESCRS Meeting: Presbyopia-Correcting IOLs Dominate Meeting Agenda

Trifocal designs have significant PC-IOL market share in Europe; Alcon adds to the available options with its PanOptix lens.

September 17, 2015:

2015 ESCRS Meeting: Other New IOLs and IOL Technology

Surgeons reported excellent results with Calhoun Vision’s Light-Adjustable Lens.

September 17, 2015:

2015 ESCRS Meeting: Femtosecond Laser Cataract Surgery

Sessions provided mixed data on technology, as most surgeons remain undecided.

September 17, 2015:

2015 ESCRS Meeting: Automated Manual Capsulotomy Investigational Devices

At least four devices are in various stages of development; CAPSULaser says it plans to launch its system in late 2015.

September 17, 2015:

2015 ESCRS Meeting: New Glaucoma Treatment Options

The Glaukos iStent was a common topic, though the US remains its center of popularity; other MIGS devices are getting closer to commercialization.

September 17, 2015:

2015 ESCRS Meeting: Commercial Experience with Corneal Inlays

At least 12 papers discussed the four inlays currently commercialized; AcuFocus reported that more than 40 US ophthalmologists are now offering the KAMRA.

September 17, 2015:

2015 ESCRS Meeting: OCT Angiography, Biometry Advances Attract High Interest

OCT angiography devices allow visibility of blood flow with significantly more precision.

September 17, 2015:

Allergan Acquires AqueSys, Gains Global Rights to XEN45 MIGS Stent

Terms of the deal include $300 million up front, plus milestone payments related to AqueSys' lead development programs.

September 17, 2015:

Valeant Acquires Retinal Device Maker Synergetics to Complement Own Product Line

Valeant will pay $6.50 per Synergetics share, a 48 percent premium to the stock’s closing price on Sept. 1.

September 17, 2015:

Sun Pharmaceutical of India Outbids QLT for InSite Vision

Sun Pharma was the third suitor seeking to acquire InSite, stepping into the process Sept. 3.

September 17, 2015:

Glaucoma surgical device market to grow to nearly $1.1 billion over the next five years

Advanced Technology Glaucoma Surgery devices expected to drive future market growth.

September 17, 2015:

Changes Loom in Retinal Pharma Market with Robust Growth Forecast through 2020

Segment is forecast to climb to $16.5 billion by 2020 at a CAGR of 12 percent.

September 17, 2015:

LASIK Vision Institute Begins Marketing to NASCAR Fans

Demographics of racing enthusiasts match up well with target market for refractive surgery.

September 17, 2015:

Novartis Targets 2016 for Human Testing of Contacts for Presbyopia

Google is collaborating on development of the lens under an agreement with Novartis’ Alcon division.

September 17, 2015:

Survey: Ancillary Services Creating Financial Impact for US Surgeons

Many practices have moved in this direction to offset declines in Medicare reimbursement.

September 17, 2015:

Former Bausch + Lomb Headquarters to House Photonics Incubator

The technology accelerator is a partnership between the federal government, New York, and a coalition of universities, nonprofits, industry, and other states.

September 17, 2015:

Majority of Ophthalmologists Dissatisfied with Earnings

Ophthalmologists receive average compensation of $292,000 annually, according to Medscape’s 2015 Physician Compensation Report.

September 17, 2015:

September 2015 News Briefs

Social media